Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.
暂无分享,去创建一个
[1] L. Shaw,et al. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood. , 1999, Clinical chemistry.
[2] K. Linnet,et al. Necessary sample size for method comparison studies based on regression analysis. , 1999, Clinical chemistry.
[3] U. Garg,et al. Comparison of the Abbott IMx Tacrolimus I and Tacrolimus II assays. , 1998, Clinical Chemistry.
[4] U. Christians,et al. Pitfalls in monitoring tacrolimus (FK 506). , 1997, Therapeutic drug monitoring.
[5] A. Grygotis,et al. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. , 1997, Therapeutic drug monitoring.
[6] A. Alak,et al. An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay. , 1997, Journal of pharmaceutical and biomedical analysis.
[7] A. Alak. Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. , 1997, Therapeutic drug monitoring.
[8] P. Wong,et al. A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents. , 1996, Therapeutic drug monitoring.
[9] U. Christians,et al. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients. , 1996, Clinical chemistry.
[10] S. Pond,et al. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. , 1996, Clinical chemistry.
[11] T. Starzl,et al. Clinical Pharmacokinetics of Tacrolimus , 1995, Clinical pharmacokinetics.
[12] U. Christians,et al. Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506) , 1995 .
[13] K. Iwasaki,et al. Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[14] P. Wallemacq,et al. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. , 1993, Clinical chemistry.
[15] H. Schiebel,et al. Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients. , 1992, Clinical chemistry.
[16] S. Vincent,et al. In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. , 1992, Archives of biochemistry and biophysics.
[17] G. Kootstra,et al. FK 506: monitoring in plasma or in whole blood? , 1991, Transplantation proceedings.
[18] M. Okuhara,et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. , 1987, The Journal of antibiotics.